These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 29843394)

  • 21. Racial and Ethnic Disparities in Renal Cell Carcinoma: An Analysis of Clinical Characteristics.
    Batai K; Harb-De la Rosa A; Lwin A; Chaus F; Gachupin FC; Price E; Lee BR
    Clin Genitourin Cancer; 2019 Feb; 17(1):e195-e202. PubMed ID: 30459061
    [TBL] [Abstract][Full Text] [Related]  

  • 22. BAP1 is overexpressed in black compared with white patients with Mx-M1 clear cell renal cell carcinoma: A report from the cancer genome atlas.
    Paulucci DJ; Sfakianos JP; Yadav SS; Badani KK
    Urol Oncol; 2016 Jun; 34(6):259.e9-259.e14. PubMed ID: 26854086
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Renal cell cancer histological subtype distribution differs by race and sex.
    Lipworth L; Morgans AK; Edwards TL; Barocas DA; Chang SS; Herrell SD; Penson DF; Resnick MJ; Smith JA; Clark PE
    BJU Int; 2016 Feb; 117(2):260-5. PubMed ID: 25307281
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Biomarkers for evaluating racial disparities in clinical outcome in patients with renal cell carcinoma.
    Harris WB
    Mol Aspects Med; 2015 Nov; 45():47-54. PubMed ID: 26071853
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Renal cell cancer among African Americans: an epidemiologic review.
    Lipworth L; Tarone RE; McLaughlin JK
    BMC Cancer; 2011 Apr; 11():133. PubMed ID: 21486465
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Contemporary epidemiology of renal cell carcinoma: perspectives of primary prevention.
    Weikert S; Ljungberg B
    World J Urol; 2010 Jun; 28(3):247-52. PubMed ID: 20390283
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Commentary on "Racial disparity in renal cell carcinoma patient survival according to demographic and clinical characteristics." Chow WH, Shuch B, Linehan WM, Devesa SS, Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD.: Cancer 2013; 119(2):388-94. [Epub 2012 Nov 12]. doi: 10.1002/cncr.27690.
    Hollenbeck BK
    Urol Oncol; 2014 May; 32(4):512. PubMed ID: 24767686
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Racial Disparities in Histology and Short-Term Renal Functional Outcomes Following Robotic Nephron-Sparing Surgery.
    Wang JC; Lai WR; Traore EJ; Liu J; Sholl AB; Mandava SH; Maddox MM; Mitchell GC; Viriyasiripong S; Silberstein JL; Kittles R; Lee BR
    Clin Genitourin Cancer; 2017 Apr; 15(2):203-206. PubMed ID: 27554583
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A genome-wide association study of renal cell carcinoma among African Americans.
    Purdue MP; Ye Y; Wang Z; Colt JS; Schwartz KL; Davis FG; Rothman N; Chow WH; Wu X; Chanock SJ
    Cancer Epidemiol Biomarkers Prev; 2014 Jan; 23(1):209-14. PubMed ID: 24220910
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prevalence and Characteristics of Patients with Suspected Inherited Renal Cell Cancer: Application of the ACMG/NSGC Genetic Referral Guidelines to Patient Cohorts.
    Truong H; Hegarty SE; Gomella LG; Kelly WK; Trabulsi EJ; Lallas CD; Giri VN
    J Genet Couns; 2017 Jun; 26(3):548-555. PubMed ID: 28101821
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Racial and ethnic differences in survival in contemporary metastatic renal cell carcinoma patients, according to alternative treatment modalities.
    Luzzago S; Palumbo C; Rosiello G; Knipper S; Pecoraro A; Nazzani S; Tian Z; Musi G; Montanari E; Shariat SF; Saad F; Briganti A; de Cobelli O; Karakiewicz PI
    Cancer Causes Control; 2020 Mar; 31(3):263-272. PubMed ID: 31993859
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Disparities in uterine cancer epidemiology, treatment, and survival among African Americans in the United States.
    Long B; Liu FW; Bristow RE
    Gynecol Oncol; 2013 Sep; 130(3):652-9. PubMed ID: 23707671
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Racial disparities in survival among patients with advanced renal cell carcinoma in the targeted therapy era.
    Rose TL; Deal AM; Krishnan B; Nielsen ME; Smith AB; Kim WY; Milowsky MI
    Cancer; 2016 Oct; 122(19):2988-95. PubMed ID: 27341404
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hematuria in sickle cell anemia--not always benign: evidence for excess frequency of sickle cell anemia in African Americans with renal cell carcinoma.
    Baron BW; Mick R; Baron JM
    Acta Haematol; 1994; 92(3):119-22. PubMed ID: 7871949
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Race affects access to nephrectomy but not survival in renal cell carcinoma.
    Zini L; Perrotte P; Capitanio U; Jeldres C; Duclos A; Arjane P; Villers A; Montorsi F; Patard JJ; Karakiewicz PI
    BJU Int; 2009 Apr; 103(7):889-93. PubMed ID: 19021607
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Renal Cancer Patients with Unknown Ethnicity in Cancer Registry Data: Comparisons to Patients with Known Ethnicity.
    Lin J; Butts E; Rockswold PD; Shriver CD; Zhu K
    J Registry Manag; 2015; 42(2):62-9. PubMed ID: 26360107
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Black race may be associated with worse overall survival in renal cell carcinoma patients.
    Anastos H; Martini A; Waingankar N; Paulucci DJ; Beksac AT; Daza J; Patel HV; Gin GE; Sfakianos JP; Badani KK
    Urol Oncol; 2020 Dec; 38(12):938.e9-938.e17. PubMed ID: 32950398
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clear Cell Papillary Renal Cell Carcinoma: New Clinical and Imaging Characteristics.
    Wang K; Zarzour J; Rais-Bahrami S; Gordetsky J
    Urology; 2017 May; 103():136-141. PubMed ID: 28130179
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The effect of race and gender on the surgical management of the small renal mass.
    Kates M; Whalen MJ; Badalato GM; McKiernan JM
    Urol Oncol; 2013 Nov; 31(8):1794-9. PubMed ID: 22687567
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of African-American race on cancer specific mortality differs according to clear cell vs. non-clear cell histologic subtype in metastatic renal cell carcinoma.
    Marchioni M; Harmouch SS; Nazzani S; Bandini M; Preisser F; Tian Z; Kapoor A; Cindolo L; Briganti A; Shariat SF; Schips L; Karakiewicz PI
    Cancer Epidemiol; 2018 Jun; 54():112-118. PubMed ID: 29715680
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.